Encapsulation and release of calcein from herceptin-conjugated eLiposomes
Achieving an optimal therapeutic level is crucial in effectively eradicating cancer cells during treatment. However, conventional chemotherapy-associated systemic administration of anticancer agents leads to many side effects. To achieve the desired control over the target site, active targeting of...
Autores principales: | Mah Noor Zafar, William G. Pitt, Ghaleb A. Husseini |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
Elsevier
2024-03-01
|
Colección: | Heliyon |
Materias: | |
Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S2405844024039136 |
Ejemplares similares
-
Acoustically-Activated Liposomal Nanocarriers to Mitigate the Side Effects of Conventional Chemotherapy with a Focus on Emulsion-Liposomes
por: Mah Noor Zafar, et al.
Publicado: (2023-01-01) -
Ultrasound-sensitive cRGD-modified liposomes as a novel drug delivery system
por: Nour M. AlSawaftah, et al.
Publicado: (2022-12-01) -
The pH-Responsive Liposomes—The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells
por: Eirik A. L. Rustad, et al.
Publicado: (2022-05-01) -
Modeling of the In Vitro Release Kinetics of Sonosensitive Targeted Liposomes
por: Zeyad AlMajed, et al.
Publicado: (2022-12-01) -
Liposomes for the Treatment of Brain Cancer—A Review
por: Richu Raju, et al.
Publicado: (2023-07-01)